Honasa Consumer (HONASA) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
8 Jul, 2026Executive summary
Achieved 13.3% YoY revenue growth in Q4, with FY25 consolidated revenue at INR 20,669.49 million (up 7.7% YoY), and gross profit margin improving to 70.3%.
Focused on premiumization in hair care and core categories, with strategic investments in distribution, product innovation, and R&D, including the acquisition of Cosmogenesis.
Mamaearth's focus categories (face wash, shampoo, sunscreen, moisturizer, baby) now contribute ~70% of brand sales, showing double-digit growth in e-commerce and modern trade.
Young brands (BBLUNT, Aqualogica, Dr. Sheth's, STAZE, Derma Co) grew 30%+ YoY, with Derma Co achieving INR 100 crore ARR in offline channels.
Audited standalone and consolidated financial results for FY25 were approved, with unmodified audit opinions issued.
Financial highlights
Q4 FY25 revenue from operations: INR 534 crore (up 13% YoY); gross profit margin: 70.7%; EBITDA: INR 27 crore (5.1% margin); PAT: INR 25 crore (4.7% margin).
FY25 EBITDA: INR 69 crore (3.3% margin); PAT: INR 73 crore (3.5% margin); free cash at year-end: INR 82 crore; cash and bank balances at March 31, 2025: INR 331 crore.
Standalone revenue from operations for FY25 was Rs 18,657.07 million; standalone net profit was Rs 640.83 million.
Working capital improved to negative 24 days, with cash generation of INR 74 crore in Q4.
Underlying volume growth (UVG) for Q4 FY25: 21.2%; for FY25: 13.2%.
Outlook and guidance
Targeting double-digit value growth and 250 bps EBITDA margin improvement in FY26, aiming to return to FY24 EBITDA levels by year-end.
Premiumization trends in hair and skin care, and growth in suncare and face serums, are expected to drive future growth.
Project 'Neev' transition to a direct distribution model across top 50 cities is expected to enhance future distribution efficiency.
Latest events from Honasa Consumer
- Record revenue and profit growth driven by innovation, margin expansion, and strategic investments.HONASA
Q3 25/269 Jul 2026 - Q3 FY25 revenue up 6% YoY, 5% PAT margin, and non-Mamaearth brands lead growth.HONASA
Q3 24/2530 Jun 2026 - Q2 FY25 loss from inventory correction; focus categories and young brands drive adjusted growth.HONASA
Q2 24/2519 Jun 2026 - Targeting INR 5,500+ Cr revenue and 15%+ EBITDA by FY31 through innovation and omni-channel growth.HONASA
Investor Day 25/26 presentation10 Jun 2026 - Record revenue and profit growth, maiden dividend, and strong performance from key brands.HONASA
Q4 25/2625 May 2026 - Q1 FY25 delivered 19.3% revenue growth, record margins, and robust innovation, with guidance reaffirmed.HONASA
Q1 24/252 Feb 2026 - Record revenue and profit, double-digit growth in focus categories, and margin expansion.HONASA
Q1 25/2627 Nov 2025 - Q2 FY26 delivered 22.5% revenue growth, record margins, and strategic expansion in oral care.HONASA
Q2 25/2612 Nov 2025